share_log

Exopharm Ltd: Appendix 4D and Half Year Report for period 31 December 2022

Feb 27, 2023 05:05
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.